Crossmark

Model-Informed Therapeutic Drug Monitoring of Meropenem in Critically Ill Patients: Improvement of the Predictive Ability of Literature Models with the PRIOR Approach

Crossref DOI link: https://doi.org/10.1007/s13318-021-00681-5

Published Online: 2021-04-08

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chan Kwong, Anna https://orcid.org/0000-0002-1524-7490
O’Jeanson, Amaury

Khier, Sonia
License Information

Text and Data Mining valid from 2021-04-08

Version of Record valid from 2021-04-08
More Information

Article History

Accepted: 10 March 2021

First Online: 8 April 2021

Declarations

:

: No funding was received for either this study or for the preparation of this manuscript.

: Anna Chan Kwong, Amaury O’Jeanson, and Sonia Khier declare no conflicts of interest that could have influenced the submitted work.

: The study protocol was approved by the Ethics Committee 2019_IRB-MTP_03-01.

: Not applicable as this was a non-interventional retrospective study; patients were informed of their right of opposition to data collection.

: Not applicable.

: On demand (email: sonia.khier@umontpellier.fr).

: Code available in Supplementary Materials.

: ACK performed the analyses and wrote the original manuscript, tables and figures. AOJ collected the data, performed the literature review, and contributed to writing the manuscript, tables and figures. SK supervised the work, reviewed the analyses, and contributed to writing the manuscript, tables, and figures.

Document is current

Any future updates will be listed below